• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胆管癌危险因素分析、糖尿病和乙型肝炎病毒感染在肝内和肝外胆管癌中的作用:一项基于病例的中国回顾性研究

Analysis of risk factors of cholangiocarcinoma, role of diabetes mellitus and hepatitis B virus infection in the intrahepatic and extrahepatic cholangiocarcinoma: a retrospective case-based study in China.

作者信息

Rasadul Hasan Md, Kang Peng-Cheng, Li Jing-Lin, Ma Shi-Hui, Duan Cheng-Hong, Zhao Xu-Dong, Cui Yun-Fu

机构信息

Department of Biliary-Pancreatical Surgery, General Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, 150086, Heilongjiang Province, China.

出版信息

Infect Agent Cancer. 2025 Jul 15;20(1):46. doi: 10.1186/s13027-025-00681-z.

DOI:10.1186/s13027-025-00681-z
PMID:40665446
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12265379/
Abstract

BACKGROUND

The cause and carcinogenesis of cholangiocarcinoma (CCA) remain unclear. In this study, we conducted a population-based case-control study in China to evaluate the effects of diabetes mellitus (DM), hepatitis B virus (HBV) infection, and other potential risk factors for cholangiocarcinoma (CCA).

METHODS

A hospital-based, case-control study was conducted, including 245 CCA patients (168 with extrahepatic cholangiocarcinoma (eCCA) and 77 with intrahepatic cholangiocarcinoma (iCCA), diagnosed at The Second Affiliated Hospital of Harbin Medical University in China between January 2019 and June 2024, along with 490 healthy controls matched in a 2:1 ratio. Conditional logistic regression and the synergism index were used to analyze risk factors for cholangiocarcinoma and their potential correlations.

RESULTS

There was an association between DM, HBV infection, cholelithiasis, choledocholithiasis, hepatolithiasis, and thyroid diseases were significantly and positively correlated with CCA, with adjusted odds ratios (AOR = 1.53; 95% CI = 1.26-1.85; P < 0.001), (AOR = 2.55; 95% CI = 1.25-5.20; P < 0.010), (AOR = 1.71; 95% CI = 1.14-2.58; P < 0.009), (AOR = 4.67; 95% CI = 1.76-12.37; P < 0.002), (AOR = 3.00; 95% CI = 1.24-7.25; P < 0.015), and (AOR = 5.46; 95% CI = 2.04-14.60; P < 0.001) respectively. A synergistic interaction between HBV infection and DM was investigated using an interactive bar chart. In the subgroup analyses, the results for eCCA included DM (AOR = 1.40; 95% CI = 1.10-1.78; P < 0.006), cholelithiasis (AOR = 1.60; 95% CI = 1.14-2.31; P < 0.013), CBD stones (AOR = 4.05; 95% CI = 1.47-11.12; P < 0.007), hepatolithiasis (AOR = 5.80; 95% CI = 1.50-22.40; P < 0.010), and thyroid diseases (AOR = 11.18; 95% CI = 2.57-48.5; P < 0.001), all of which were significant for eCCA. Whereas DM (AOR = 2.61; 95%CI = 1.52-4.48; P < 0.001), cholelithiasis (AOR = 4.34; 95%CI = 1.53-12.34; P < 0.006), hepatolithiasis (AOR = 3.55; 95%CI = 1.05-12.00; P < 0.042), and HBV infection (AOR = 3.55; 95%CI = 1.55-8.15; P < 0.003) were significant risk factors for iCCA. Synergistic interaction between HBV infection and DM was also observed, resulting in a stronger association. Furthermore, a history of cholecystectomy (AOR = 0.39; 95%CI = (0.15-0.99); p < 0.048) demonstrates a protective function.

CONCLUSION

This Chinese study found that DM is an independent risk factor for CCA, particularly iCCA, and also increases the risk of eCCA. HBV infection is exclusively associated with iCCA, whereas choledocholithiasis, hepatolithiasis, and DM can cause both eCCA and iCCA. CBD stones enhance CCA risk, especially eCCA. By understanding this synergy, effective prevention methods for high-risk CCA may be established.

摘要

背景

胆管癌(CCA)的病因和致癌机制仍不清楚。在本研究中,我们在中国进行了一项基于人群的病例对照研究,以评估糖尿病(DM)、乙型肝炎病毒(HBV)感染及其他胆管癌潜在危险因素的影响。

方法

开展了一项基于医院的病例对照研究,纳入245例CCA患者(168例肝外胆管癌(eCCA)和77例肝内胆管癌(iCCA)),于2019年1月至2024年6月在中国哈尔滨医科大学附属第二医院确诊,同时纳入490名按2:1比例匹配的健康对照。采用条件logistic回归和协同指数分析胆管癌的危险因素及其潜在相关性。

结果

DM、HBV感染、胆结石、胆总管结石、肝内结石和甲状腺疾病与CCA显著正相关,校正比值比分别为(AOR = 1.53;95%CI = 1.26 - 1.85;P < 0.001)、(AOR = 2.55;95%CI = 1.25 - 5.20;P < 0.010)、(AOR = 1.71;95%CI = 1.14 - 2.58;P < 0.009)、(AOR = 4.67;95%CI = 1.76 - (此处原文有误,应为12.37);P < 0.002)、(AOR = 3.00;95%CI = 1.24 - 7.25;P < 0.015)和(AOR = 5.46;95%CI = 2.04 - 14.60;P < 0.001)。使用交互式条形图研究了HBV感染与DM之间的协同相互作用。在亚组分析中,eCCA的结果包括DM(AOR = 1.40;95%CI = 1.10 - 1.78;P < 0.006)、胆结石(AOR = 1.60;95%CI = 1.14 - 2.31;P < 0.013)、胆总管结石(AOR = 4.05;95%CI = 1.47 - 此处原文有误,应为11.12;P < 0.007)、肝内结石(AOR = 5.80;95%CI = 1.50 - 22.40;P < 0.010)和甲状腺疾病(AOR = 11.18;95%CI = 2.57 - 48.5;P < 0.001),所有这些对eCCA均有显著意义。而DM(AOR = 2.61;95%CI = 1.52 - 4.48;P < 0.001)、胆结石(AOR = 4.34;95%CI = 1.53 - 12.34;P < 0.006)、肝内结石(AOR = 3.55;95%CI = 1.05 - 12.00;P < 0.042)和HBV感染(AOR = 3.55;95%CI = 1.55 - 8.15;P < 0.003)是iCCA的显著危险因素。还观察到HBV感染与DM之间的协同相互作用,导致更强的关联。此外,胆囊切除术史(AOR = 0.39;95%CI = (0.15 - 0.99);p < 0.048)显示出保护作用。

结论

这项中国研究发现,DM是CCA的独立危险因素,尤其是iCCA,也增加了eCCA的风险。HBV感染仅与iCCA相关,而胆总管结石、肝内结石和DM可导致eCCA和iCCA。胆总管结石增加CCA风险,尤其是eCCA。通过了解这种协同作用,可能建立针对高危CCA有效的预防方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3232/12265379/e6fee7410cf1/13027_2025_681_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3232/12265379/5d4d37385008/13027_2025_681_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3232/12265379/821e69eb7f33/13027_2025_681_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3232/12265379/fb412ddb1d4b/13027_2025_681_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3232/12265379/e6fee7410cf1/13027_2025_681_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3232/12265379/5d4d37385008/13027_2025_681_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3232/12265379/821e69eb7f33/13027_2025_681_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3232/12265379/fb412ddb1d4b/13027_2025_681_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3232/12265379/e6fee7410cf1/13027_2025_681_Fig4_HTML.jpg

相似文献

1
Analysis of risk factors of cholangiocarcinoma, role of diabetes mellitus and hepatitis B virus infection in the intrahepatic and extrahepatic cholangiocarcinoma: a retrospective case-based study in China.胆管癌危险因素分析、糖尿病和乙型肝炎病毒感染在肝内和肝外胆管癌中的作用:一项基于病例的中国回顾性研究
Infect Agent Cancer. 2025 Jul 15;20(1):46. doi: 10.1186/s13027-025-00681-z.
2
Non-alcoholic fatty liver disease as a risk factor for cholangiocarcinoma: a systematic review and meta-analysis.非酒精性脂肪性肝病作为胆管癌的危险因素:一项系统评价和荟萃分析。
BMC Gastroenterol. 2017 Dec 8;17(1):149. doi: 10.1186/s12876-017-0696-4.
3
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
4
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
5
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
8
Pharmacological interventions for acute hepatitis B infection: an attempted network meta-analysis.急性乙型肝炎感染的药物干预:一项网状Meta分析尝试
Cochrane Database Syst Rev. 2017 Mar 21;3(3):CD011645. doi: 10.1002/14651858.CD011645.pub2.
9
PTEN deficiency induces an extrahepatic cholangitis-cholangiocarcinoma continuum via aurora kinase A in mice.PTEN 缺失通过小鼠中的极光激酶 A 诱导肝外胆管炎-胆管癌连续病变。
J Hepatol. 2024 Jul;81(1):120-134. doi: 10.1016/j.jhep.2024.02.018. Epub 2024 Feb 28.
10
Systematic review on urine albumin testing for early detection of diabetic complications.关于尿白蛋白检测用于早期发现糖尿病并发症的系统评价。
Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. doi: 10.3310/hta9300.

本文引用的文献

1
New dimension in viral hepatitis research.病毒性肝炎研究的新维度。
eGastroenterology. 2024 Oct 2;2(3):e100136. doi: 10.1136/egastro-2024-100136. eCollection 2024 Sep.
2
Risk factors of primary liver cancer initiation associated with tumour initiating cell emergence: novel targets for promising preventive therapies.与肿瘤起始细胞出现相关的原发性肝癌发生的危险因素:有前景的预防性治疗的新靶点。
eGastroenterology. 2023 Aug 9;1(1):e100010. doi: 10.1136/egastro-2023-100010. eCollection 2023 Jun.
3
Recent insights into the pathogenesis and therapeutic targets of chronic liver diseases.
慢性肝病发病机制及治疗靶点的最新见解
eGastroenterology. 2023 Oct;1(2). doi: 10.1136/egastro-2023-100020.
4
Clinical treatment of cholangiocarcinoma: an updated comprehensive review.胆管癌的临床治疗:最新综合综述。
Ann Hepatol. 2022 Sep-Oct;27(5):100737. doi: 10.1016/j.aohep.2022.100737. Epub 2022 Jul 7.
5
Cholangiocarcinoma: Epidemiology and risk factors.胆管癌:流行病学和危险因素。
Liver Int. 2019 May;39 Suppl 1:19-31. doi: 10.1111/liv.14095. Epub 2019 Mar 24.
6
Emerging molecular therapeutic targets for cholangiocarcinoma.胆管癌的新兴分子治疗靶点。
J Hepatol. 2017 Sep;67(3):632-644. doi: 10.1016/j.jhep.2017.03.026. Epub 2017 Apr 5.
7
Cholangiocarcinoma.胆管癌。
Lancet. 2014 Jun 21;383(9935):2168-79. doi: 10.1016/S0140-6736(13)61903-0. Epub 2014 Feb 26.
8
Evaluation of risk factors for extrahepatic cholangiocarcinoma: ABO blood group, hepatitis B virus and their synergism.评估肝外胆管癌的危险因素:ABO 血型、乙型肝炎病毒及其协同作用。
Int J Cancer. 2013 Oct 15;133(8):1867-75. doi: 10.1002/ijc.28196. Epub 2013 May 8.
9
Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update.胆管癌诊断和治疗指南:更新版。
Gut. 2012 Dec;61(12):1657-69. doi: 10.1136/gutjnl-2011-301748. Epub 2012 Aug 15.
10
Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma.原发性肝癌发病机制中是否存在共同因素?肝内胆管癌危险因素的荟萃分析。
J Hepatol. 2012 Jul;57(1):69-76. doi: 10.1016/j.jhep.2012.02.022. Epub 2012 Mar 13.